These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 15260512)
1. Use of calcium channel antagonists for the treatment of hypertension in the elderly. Steffen HM Drugs Aging; 2004; 21(9):565-81. PubMed ID: 15260512 [TBL] [Abstract][Full Text] [Related]
2. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials]. Oparil S; Bakir SE Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856 [TBL] [Abstract][Full Text] [Related]
3. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs. Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022 [TBL] [Abstract][Full Text] [Related]
4. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916 [TBL] [Abstract][Full Text] [Related]
5. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. Tuomilehto J; Rastenyte D; Birkenhäger WH; Thijs L; Antikainen R; Bulpitt CJ; Fletcher AE; Forette F; Goldhaber A; Palatini P; Sarti C; Fagard R N Engl J Med; 1999 Mar; 340(9):677-84. PubMed ID: 10053176 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2. Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721 [TBL] [Abstract][Full Text] [Related]
7. Current treatment of patients with hypertension: therapeutic implications of INSIGHT. Taddei S; Ghiadoni L; Salvetti A Drugs; 2003; 63(14):1435-44. PubMed ID: 12834362 [TBL] [Abstract][Full Text] [Related]
8. Calcium channel antagonists in the treatment of hypertension. Weber MA Am J Cardiovasc Drugs; 2002; 2(6):415-31. PubMed ID: 14727956 [TBL] [Abstract][Full Text] [Related]
9. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW; JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064 [TBL] [Abstract][Full Text] [Related]
10. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Hansson L; Hedner T; Lund-Johansen P; Kjeldsen SE; Lindholm LH; Syvertsen JO; Lanke J; de Faire U; Dahlöf B; Karlberg BE Lancet; 2000 Jul; 356(9227):359-65. PubMed ID: 10972367 [TBL] [Abstract][Full Text] [Related]
11. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014 [TBL] [Abstract][Full Text] [Related]
12. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ; JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465 [TBL] [Abstract][Full Text] [Related]
15. Treatment of arterial hypertension with diuretics, beta- and calcium channel blockers in old patients. Nikolaus T; Sommer N; Becker C Z Gerontol Geriatr; 2000 Dec; 33(6):427-32. PubMed ID: 11201012 [TBL] [Abstract][Full Text] [Related]
16. Dihydropyridine calcium channel antagonists in the management of hypertension. Epstein BJ; Vogel K; Palmer BF Drugs; 2007; 67(9):1309-27. PubMed ID: 17547473 [TBL] [Abstract][Full Text] [Related]
17. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension. Thomas GN; Chan P; Tomlinson B Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636 [TBL] [Abstract][Full Text] [Related]
18. Dihydropyridine calcium-channel blockers for antihypertensive treatment in older patients--evidence from the Systolic Hypertension in Europe Trial. Staessen JA; Thijs L; Celis H; Gasowski J; Wang JG; Fagard RH; S Afr Med J; 2001 Dec; 91(12):1060-8. PubMed ID: 11845604 [TBL] [Abstract][Full Text] [Related]
19. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Pahor M; Psaty BM; Alderman MH; Applegate WB; Williamson JD; Cavazzini C; Furberg CD Lancet; 2000 Dec; 356(9246):1949-54. PubMed ID: 11130522 [TBL] [Abstract][Full Text] [Related]
20. Diuretics for cardiovascular prevention in the elderly. Hanon O; Seux ML; Lenoir H; Rigaud AS; Girerd X; Forette F J Hum Hypertens; 2004 Dec; 18 Suppl 2():S15-22. PubMed ID: 15592568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]